PORTLAND, Ore. - The mayor of Portland, Ore., has conceded defeat in an effort to add fluoride to the city's drinking water.

NEW YORK, N.Y. - Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.

WINNIPEG - A man found not criminally responsible for beheading a fellow passenger on a Greyhound bus in Manitoba has been granted more privileges.

OTTAWA - Health Canada has completed a safety review of the anti-acne medication Diane-35 and determined the drug’s benefits outweigh its risks when appropriately used.

The benefits of Diane-35, an acne drug that is prescribed as birth control, outweigh its risks, Health Canada says.

A snapping turtle injured by a car in Ontario has been airlifted more than 400 kilometres to an animal hospital, and is now on a slow road to recovery.

A study out of the U.K. suggests that while it may provide an initial sense of relief and well-being, over the long-term, retirement is bad for your health, increasing the likelihood of developing depression and at least one physical illness.

It's the end of a long, tough and very physically demanding television season for "Beauty and The Beast" star Jay Ryan, and with the finale of the show rolling out tonight on The CW, the actor is in very good spirits.

RCMP are crediting "overwhelming" community response for the speedy recovery of a missing elderly couple.

A Montreal mother whose newborn was taken away after a false-positive drug test says she's vindicated now that the hospital has deemed her complaint "well-founded."

A Montreal mother whose newborn was taken away after a false-positive drug test says she's vindicated now that the hospital has deemed her complaint "well founded" and ordered changes.

CHICAGO - In the new psychiatric manual of mental disorders, grief soon after a loved one's death can be considered major depression. Extreme childhood temper tantrums get a fancy name. And certain "senior moments" are called "mild neurocognitive disorder."

WASHINGTON - The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.